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ABSTRACT
Biological and chemical DNA fragmentation gener-
ates DNA molecules with a variety of termini, includ-
ing blunt ends and single-stranded overhangs. We
have developed a Next Generation Sequencing (NGS)
assay, XACTLY, to interrogate the termini of frag-
mented DNA, information traditionally lost in stan-
dard NGS library preparation methods. Here we de-
scribe the XACTLY method, showcase its sensitivity
and specificity, and demonstrate its utility in in vitro
experiments. The XACTLY assay is able to report rela-
tive abundances of all lengths and types (5′ and 3′) of
single-stranded overhangs, if present, on each DNA
fragment with an overall accuracy between 80–90%.
In addition, XACTLY retains the sequence of each na-
tive DNA molecule after fragmentation and can cap-
ture the genomic landscape of cleavage events at
single nucleotide resolution. The XACTLY assay can
be applied as a novel research and discovery tool for
fragmentation analyses and in cell-free DNA.
INTRODUCTION
The termini of fragmented DNA contain clues that can
reflect their molecular history and the fragmentation pro-
cesses that created them (1–5). To characterize DNA ter-
mini via high-throughput sequencing, DNA molecules
must first be converted into sequencing libraries, which re-
quires ligation of DNA adapters (6). To prepare the tem-
plate for ligation, most library preparation protocols end-
repair the termini of each double-stranded DNA (dsDNA)
molecule, commonly using T4 DNA polymerase to fill in
5′ overhangs and digest 3′ overhangs (7). This step renders
all input DNAmolecules uniformly ready for T/Aor blunt-
end adapter ligation while erasing the original state of DNA
termini. A variation of this procedure uses Tn5 transposase
to cleave the DNA template and deliver adapters (8), again
erasing the native state of the termini of the input DNA
molecules.
For next-generation sequencing (NGS) applications like
genome assembly, the loss or alteration of DNA termini
is inconsequential. There are cases, however, where frag-
mentation profiles observed in vitro at DNA termini can
reveal the precise effects of DNA digestion or cleavage.
For example, blunt ends or overhanging termini can re-
sult from breakage following deliberate mechanical or en-
zymatic manipulation (e.g. restriction digest, sonication,
acoustic shearing). In vivo, DNA breaks are formed during
both normal and pathological physiological processes, such
as from damaging ionizing radiation or, more commonly,
through the activation of nucleases during cell-death. Upon
cell-death, genomic DNA is degraded and released where
it can later be recovered from biofluids as short, cell-free
DNA fragments. In particular, the apoptotic endonucle-
ase DFF40/CAD has been shown to cleave dsDNA leav-
ing a mixture of blunt ends and one base pair 5′ overhangs
(3). Early necrotic cells, on the other hand, reportedly leave
DNA with only 5′ overhangs (2).
Traditional approaches to detect fragmentation and the
resulting DNA termini that follow cell death or other nu-
clease activity rely on standard molecular biology methods
(1,2,9–11), e.g. gel electrophoresis/comet assays (10,12,13),
in situ ligation and PCR (1), and DNA labeling such as
TUNEL (14). These methods are widely available and can,
in a few cases, provide nucleotide resolution at termini, but
are generally low-throughput and require targeting prede-
fined loci or specific overhang types. Furthermore they of-
ten lack sequence information and genome context for the
breakpoints.
While NGS methods like BLESS (15), BLISS (15), and
EndSeq (16,17) are high-throughput and can be performed
without a priori knowledge of cleavage sites, they pri-
marily focus on identifying where double-stranded DNA
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breaks (DSBs) occur in situ in the genomes of living or cul-
tured cells. These are important questions for investigating
how cells repair DNA damage, how the accumulation of
DSBs contributes to genomic instability, the effects of pro-
grammable nucleases on DNA duplexes (18), or in the case
of gene-editing tools, off-target binding sites (19). How-
ever, these NGS methods integrate DNA end-repair steps
into their library preparation workflows prior to sequenc-
ing adapter ligation. The end-repair stepmay biochemically
erase the precise nucleotide position of the break and more
importantly never indicates the type of DNA termini pro-
duced by the cleavage mechanism(s), 3′ or 5′ overhangs, for
example. Furthermore, these methods are not intended for
nakedDNAsubstrates that have undergone cleavage, for ex-
ample, in cell-free or in vitro environments.
Here, we describe a simple ligation-based NGS library
approach, XACTLY, that provides comprehensive informa-
tion about the native-state of the termini of extracted frag-
mented DNA. By omitting the standard DNA end-repair
step, XACTLY libraries encode the type of break at each
molecule terminus using custom sequencing adapters. The
end result of XACTLY is a high-throughput NGS assay
that provides nucleotide resolution of DNA fragmentation
across the genome, requiring no knowledge of expected
cleavage patterns. Our method for generating Illumina-
compatible dsDNA sequencing libraries introduces into the
sequencing adapter a unique identifier that encodes the
overhang type (3′, 5′ or blunt), length, and sequence at
the DNA termini. Here, we first demonstrate the accuracy
of XACTLY using (i) a population of control oligos with
known single-stranded overhangs and (ii) DNA digestion
products from specific restriction enzymes.We then describe
the distribution of native termini of dsDNA fragments pro-
duced by common methods of enzymatic and mechanical
shearing using the Diagenode Bioruptor, DNaseI, and Mi-
crococcal nuclease. Finally, using XACTLY, we show that
common procedures for collecting human blood vary in
their ability to protect circulating cell-free DNA fragments
from degradation by nucleases present in the blood.
MATERIALS AND METHODS
DNA templates for XACTLY experiments
Synthetic control oligos. Synthetic control oligos (Supple-
mentary Table S1) were designed using a random sequence
generator at 50% GC content. Sequences matching any
known organism in public databases were removed. Each
control molecule (n = 12) is a unique 50 bp sequence of
double-stranded DNA with one blunt-end, and one 3′ or
5′ single-stranded overhang of random sequence, 1–6 nu-
cleotides in length. Because each control is a unique se-
quence, it serves as its own barcode indicating the struc-
ture of the oligo. Oligos were synthesized using standard de-
salting purification and duplexed by Integrated DNATech-
nologies (IDT); all random nucleotides were ‘hand-mixed’
to reduce synthesis bias. Control oligos were pooled to-
gether in an equimolar ratio.
NA12878 genomic DNA (gDNA). NA12878 gDNA was
purchased from the Coriell Institute for Medical Research,
was prepared for XACTLY ligation in several ways. Me-
chanical shearing: NA12878 was sheared to an average
length of 350 bp using a Bioruptor Pico (Diagenode) and
manufacturer’s instructions. ShearedDNAwas then size se-
lected from 200 to 600 bp using a Pippen Prep dye free 2%
gel (Sage Sciences) following manufacturer’s instructions.
Restriction enzyme digest: 1 g of NA12878 was digested
in a 50 l reaction using 10 units of MluCI (New England
Biolabs) at 37◦C for 1 h. Digested DNA was purified us-
ing 2× AMPure beads (Beckman Coulter) following man-
ufacturer’s instructions. After purification DNA was size-
selected from 200 to 600 bp using a Pippen Prep dye free
2% gel (Sage Sciences) and manufacturer’s instructions. En-
zymatic shearing: DNase I: 1 g of NA12878 was digested
in a 50 l reaction using 0.01 units of DNase I (New Eng-
land Biolabs) at 37◦C for 10 min and stopped with 0.1 mM
EDTA; DNA was purified as above. Micrococcal nuclease:
1 g of NA12878 was digested in a 50 l reaction using
2 units of Micrococcal nuclease (New England Biolabs) at
37◦C for 5 min and stopped with 0.1 mMEDTA; DNAwas
purified as above.
Human plasma extraction and cell-free DNA preparation.
Whole blood from deidentified donors was obtained for
in vitro investigational use from the Stanford Blood Cen-
ter in Palo Alto, CA. Blood was drawn into one of several
tube types (Supplementary Table S2). Blood plasma was
extracted from whole blood by spinning the blood collec-
tion tubes at 1800 g for 10 min at 4◦C. Without disturbing
the cell layer, the supernatant was transferred to microcen-
trifuge tubes under sterile conditions in 2 ml aliquots and
spun again at 16 000 g for 10min at 4◦C to remove cell debris
and stored at−80◦C as 1 ml aliquots. cfDNAwas extracted
from 1 ml plasma using the QiaAmp ccfDNA kit (Qiagen)
following manufacturer’s protocol. Purified cfDNA was
measured for double-stranded DNA (dsDNA) concentra-
tion using the Quant-iT high sensitivity dsDNA Assay Kit
and a Qubit Fluorometer (ThermoFisher). Purified cfDNA
was analyzed for size distribution using the Agilent TapeS-
tation 4200 and associated D1000 and D5000 high sensitiv-
ity products. Cell-free DNAwas prepared for XACTLY lig-
ation by dephosphorylation followed by 5′ phosphorylation
using the protocol detailed below (Preparing DNA termini
for adapter ligation).
Control oligo-blood spike experiments. Approximately 40
ml of whole blood was collected in four blood collection
tubes (10 ml each) from a single donor (Supplementary Ta-
ble S2). Blood from each collection tube was divided into
three equal aliquots. To evaluate the effect of blood nu-
cleases on DNA termini, a pool of our control oligos (1
pmol total per ml of whole blood) was added to aliquoted
blood collection tubes under sterile conditions. In the case
of serum tubes, because coagulation initiates from the time
of blood draw, the clot was separated at the start of the
experiment and the control oligo pool was added to 1 ml
of the supernatant prior to serum preparation. Water and
1X PBS pH7.4 were used as negative controls, substituting
for whole blood. The blood product-oligo mixtures (and
negative controls) were incubated for 0, 4 or 24 h. Im-
mediately following each time point, blood plasma extrac-
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tion was performed as above. cfDNA extractions were per-
formed from each spiked plasma sample using the Qiagen
QiaAmp ccfDNA kit. The bead binding buffer, proteinase
K and magnetic bead volumes were scaled according to the
input plasma volume. DNA termini preparation of control-
spiked cfDNA was performed as described below, followed
by XACTLY adapter ligation, nick repair and amplifica-
tion.
Ethics statement. This work is not considered human sub-
jects research under the HHS human subjects regulations
(45 CFR Part 46).
XACTLY library preparation
Preparing XACTLY sequencing adapters. Each XACTLY
adapter contains Illumina sequencer-specific priming sites
and a Unique-End-Identifier (UEI)––a barcode sequence
that indicates the length and identity (5′ or 3′) of the over-
hang, if any, present in the original molecule (Supplemen-
tary Table S3). The XACTLY adapters were synthesized us-
ing standard desalting purification and duplexed by Inte-
gratedDNATechnologies (IDT). For purposes of this study
the 13XACTLY adapters include six with 3′ overhangs (1–6
nt in length), six with 5′ overhangs (1–6 nt in length), and a
single blunt adapter (i.e. no overhang). XACTLY adapters
were not phosphorylated and thus are discouraged from
forming dimers. All 13 duplexed XACTLY adapters were
pooled in equimolar ratio and prepared for ligation by ter-
minal dephosphorylation using the following 20 l reac-
tion: 1pmol of pooled XACTLY adapters, 10 units of rapid
Shrimp Alkaline Phosphatase (New England Biolabs), 1×
CutSmart Buffer, incubated at 37◦C for 30 min followed by
a 10-min heat inactivation at 65◦C. Multiple dephosphory-
lation reactions were combined over a single QIAquick Nu-
cleotide Removal column (Qiagen) and purified according
to manufacturer’s instructions. XACTLY adapter molarity
was calculated using DNA concentration (Qubit Fluoro-
metric Quantitation) and double-stranded base pair length.
Purified XACTLY adapters could be used directly and/or
stored at −20◦C.
Preparing template DNA termini for adapter ligation. The
termini of template DNA molecules, including control oli-
gos, were prepared for adapter ligation. Up to 1 pmol, DNA
ends were dephosphorylated in a 20 l reaction using rapid
Shrimp Alkaline Phosphatase (rSAP) (New England Bio-
labs) and 1× CutSmart buffer incubated at 37◦C for 30 min
followed by a 10-min heat inactivation at 65◦C. DNA was
then 5′ phosphorylated by bringing the heat-inactivated 20
l rSAP reaction up to 40 l using 20 units of T4 Polynu-
cleotideKinase (NewEngland Biolabs), and a 5% final con-
centration of PEG 8000. The phosphorylation reaction was
carried out at 37◦C for 30 min followed by a 30-min heat
inactivation step at 65◦C.
Adapter ligation and nick repair. XACTLY ligation con-
sisted of an initial ligation step and a subsequent nick re-
pair ligation step prior to standard NGS library amplifi-
cation and indexing. First, 0.05 pmol of substrate DNA
(control/NA12878/cfDNA) was combined with 1 pmol of
XACTLY adapters in a 60 l ligation reaction with 800
units of T4 DNA ligase (New England Biolabs) and 1× T4
DNALigase Buffer, and incubated at 20◦C for 1 h, followed
by either a 2× AMPure clean for control oligos, or a 1.2×
AMPure clean for NA12878 or cfDNA. After DNA purifi-
cation, DNAwas again phosphorylated with 20 units of T4
Polynucleotide Kinase (New England Biolabs) and 1× T4
DNA ligase buffer in a 48.8 l reaction and incubated at
37◦C. After 30 min, 480 units of T4 DNA ligase was added
to the reaction and the temperature reduced to 20◦C for 15
min. Nick repair was followed by a 2× AMPure bead clean
and elution in 20 l of low TE (10 mM Tris pH 8, 0.1 mM
EDTA).
Library amplification and indexing for Illumina sequencing.
For Index PCR, 10 l of purified XACTLY ligated DNA
was combined with 1× Kapa HiFi HotStart ReadyMix
(Kapa Biosystems) and 0.4 mM final concentrations of
the Illumina-compatible IS4 primer and a single indexing
primer, as described in (7), in a 50 l reaction and ampli-
fied using the following thermal cycling conditions: 3 min
at 98◦C for initial denaturation followed by 15 cycles for
control/NA12878 or 18 cycles for cfDNA at 98◦C for 20
s, 68◦C for 30 s, 72◦C for 30 s, and finally an elongation step
of 1 min at 72◦C. After index PCR, DNA was purified with
either a 1.5× AMPure clean for control oligos, or a 1.2×
AMPure clean for NA12878/cfDNA. For each sequencing
DNA library, final molarity estimates were calculated us-
ing fragment length distribution and dsDNA concentration
(Agilent Tapestation 4200 and Qubit Fluorometric Quanti-
tation unit). Samples were then pooled and run 2 × 150 bp
cycles on an IlluminaMiSeq benchtop sequencer (following
manufacturer’s instructions) to a depth of ∼100 000 read-
pairs per sample. Step-by-step instructions for XACTLY li-
brary preparation method are detailed in the Supplemental
Protocol.
Informatic analysis
Read processing. MappingUEI-barcoded read pairs poses
a bioinformatic challengewhen templatemolecules, plus the
7-nt UEIs, are shorter than the sum of the lengths of the
forward and reverse reads. The challenge of mapping short
fragments exists because each read can extend through its
mate’s UEI sequence and possibly beyond into the Illu-
mina adapter sequence. Standard practice in studies where
short template molecules are expected, such as in the field
of ancient DNA, is simultaneously to remove adapter se-
quences and merge reads (20). Specifically, the process col-
lapses forward and reverse reads into single sequences based
on sequence similarity and a minimum amount of overlap
while trimming ends of reads that match known Illumina
adapter sequences (see SeqPrep https://github.com/jstjohn/
SeqPrep). When UEIs are present, however, a merged read
that is shorter than or equal to the read length will have
a 7-nt UEI on both ends, one of which will be reverse-
complemented. The reverse-complemented UEI from R2
has the potential to interfere with read mapping. For this
reason, we truncated each forward and reverse read wher-
ever its mate’s reverse-complemented UEI sequence was
found.
e47 Nucleic Acids Research, 2020, Vol. 48, No. 8 PAGE 4 OF 13
For each read, we first checked for the presence of a
known UEI at the start of the forward and reverse read in
each pair. UEIs were allowed to contain up to one ‘N’ base,
but no other base mismatches were allowed. If both reads
had a knownUEI sequence, we then checked whether reads
merged by searching each sequence for the reverse comple-
ment of its mate’s UEI. If neither read met this criterion,
both reads were output unchanged, since a read can only
include adapter sequence if it extends through its mate’s
UEI sequence. If both reads contained their mate’s reverse-
complemented UEI sequence, and the positions at which
themates’UEIswere encounteredmatched, then both reads
were truncated at that position. If the positions did not
match, indicating an artifact such as a chimera, both reads
were discarded. Across all control oligo experiments, an av-
erage of 3.3% of reads per library were discarded this way,
compared to 4.3% discarded for lacking a known UEI se-
quence.
Rather than storing all merged read pairs as collapsed se-
quences, we kept them as truncated read pairs, so that UEI
sequences of mates would not interfere withmapping to ref-
erence genomes. For the sake of our control oligo experi-
ments, in which relatively short known sequences were ex-
pected, we also stored collapsed sequences for read pairs
that merged using our criteria. For such sequences, we al-
lowed the bases within the merged region to contain at most
one mismatch (the chosen base at mismatching positions
was the base with the higher quality, or a random base in
the case of a tie).
To reduce the risk of contamination of our sequencing
data by the Illumina sequencing control DNA––phiX––due
to index misassignment, we first aligned all of our raw data
to the phiX genome using bwa mem (21) with default pa-
rameters. Across all experiments, reads aligning to the phiX
genome comprised on average 0.28% of the data. We ex-
tracted reads that did not map to phiX (samtools) (22) and
used these for downstream analyses.
Limiting to reverse reads. Because we found that over-
hanging adapters were less reliable when encountered on
forward (P5) rather than reverse (P7) reads (see Results
section on Accuracy), our analyses ignored forward reads
that began with an overhanging adapter. Blunt adapters
were allowed on both the forward and reverse reads. In all
cases, this filtering step was applied only when computing
the results of experiments, that is, all reads were included
when processing, merging, and aligning, but overhanging
adapters on forward reads were not allowed to affect results.
Accuracy, precision and recall measurements in control oligo
experiments. When processing control oligos we expected
all properly formed sequences to merge using our criteria
(see Read processing above), except in cases where control
oligos chained together. We defined three ways of assessing
control oligo experiments, accuracy, precision and recall.
Tomeasure accuracy, we evaluated how reliably eachUEI
ligates to its correct target. We generated 17 replicate li-
braries using an equimolar pool of control oligos contain-
ing overhangs corresponding to the overhangs types and
lengths available in the UEI adapter pool. Per library ac-
curacy is measured as the proportion of correct ligation
events within that library considering only UEIs from re-
verse reads. The overall accuracy is averaged over 17 li-
braries.
To measure precision, we computed the proportion of
UEI sequences that were ligated to the correct end of the
control oligo with the matching overhang. In this case,
we did not exclude the ends of control oligos that formed
chains, thereby assessing all DNA end available for UEI
adapter ligation. For every paired-end read (truncated as
described in Read Processing above, but not merged), we
aligned the sequence following the UEI to a reference se-
quence containing all control oligo sequences, separated by
runs of ‘N’ bases equal to the length of the longest over-
hang. The best alignment, allowing up to onemismatch and
with ‘N’ matching any base, was used to determine the cor-
rect control oligo sequence. Only non-chimeric alignments,
i.e. within the coordinates of a single control oligo sequence
were considered. Precision was then defined as the propor-
tion of reads for which the UEI at the beginning of the read
was followed by the correct type of control oligo end, in the
correct orientation.
To measure recall, we computed the proportion of con-
trol oligo ends that were correctly identified using our
adapters. First, all reads that merged using our criteria (see
Read Processing above) were considered. Next, we con-
structed a reference sequence consisting of all control oligo
sequences and their reverse complements, separated by runs
of ‘N’ bases equal in length to the longest control oligo over-
hang. To determine the control oligo type of each merged
read, we alignedmerged reads to this reference sequence us-
ing the EdlibC++ sequence alignment library (23), allowing
gaps at the beginning and end of the read in the alignment
and allowing up to one base mismatch, letting ‘N’ match
any base with no penalty. If the best alignment fell within
the coordinates of a single control oligo sequence (a non-
chimeric alignment), that control oligo was chosen as the
correct sequence. A control oligo was considered correct if
the barcode for the correct overhang was ligated to the ex-
pected overhang end of the oligo and the barcode for blunt
adapters was ligated to the opposite end.
Nucleotide composition of overhang sequence. When as-
sessing the base composition of overhang sequences, we re-
quired that all adapters be ligated to the correct type of con-
trol oligo.We considered all bases between the end of a UEI
sequence and the beginning of a control oligo sequence to
be the true sequence of the overhang.
Human DNA data processing. Paired-end reads that re-
main after filtering were truncated if necessary (see Read
Processing above) and aligned to the hg19 human reference
genome downloaded from the UCSC genome browser (24).
We used bwa aln and bwa sampe (25) with default parame-
ters for alignment, skipping theUEI sequences at the begin-
ning of the reads (-B parameter). Duplicate reads were then
removed using samtools rmdup. We counted as mapped
only reads that were in proper pairs with a minimum map
quality of 20 (samtools view –c –f66 –q20), except in the case
of the restriction enzyme experiments, in which we removed
the requirement for proper pairing (samtools view –c –f64
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–q20) due to the possibility of chaining fragments causing
chimeric alignments.
To countUEI types inmapped reads, we scanned through
the BAM files using HTSLib’s BAM parser (22) and ob-
tainedUEI sequences from the BC tag. Overhang sequences
were obtained by taking a number of bases from the begin-
ning of each read equal to the overhang length indicated by
the UEI.
Downsampling data. To evaluate whether DNA termini
profiles were affected by sequencing depth, we re-sequenced
a library replicate of Bioruptor sonicated NA12878 gDNA
(see DNA templates for XACTLY experiments above) on
a Illumina NextSeq. From 6,757,000 read pairs, we down-
sampled the raw sequencing data using seqtk sample to in-
creasingly shallow sequencing depths: 5 million, 2 million,
1 million and 0.5 million and 0.1 million read pairs. We also
included read data that were generated by sequencing the
same library on an Illumina Miseq to a depth of ∼0.2 mil-
lion reads. We then processed each of the down-sampled se-
quence files alongwith the original NextSeq andMiSeq files
as described above in Human DNA data processing.
Control oligo spike-in experiments. Some sequencing li-
braries consisted of humanDNAspikedwith control oligos.
To analyze these libraries, we first processed all sequenc-
ing reads as if the libraries contained only human DNA
(see Human DNA data processing). Then, non-human se-
quences were extracted from the alignments to the human
reference genome, by selecting unmapped reads and reads
with map quality less than 10 (using a custom technique
that can re-append barcodes to extracted read sequences).
These reads, which consisted mostly of control oligos, were
then processed the same way as other control oligo libraries.
RESULTS
Library construction
The XACTLY method assays fragmented and degraded
dsDNA termini following a standard library prepara-
tion workflow, shown schematically in Figure 1. Each
XACTLY adapter consists of three parts: the requisite
P5/P7 Illumina-based sequencing and index priming sites, a
7 bp Unique End Identifier (UEI) – a barcode encoding the
termini type, and a blunt end or a single-stranded overhang
that hybridizes and ligates to the substrate’s overhang, when
present. The overhangs are synthesized with equal propor-
tions of random sequence of length N, here up to six nu-
cleotides (nt) long. XACTLY adapters are included in ex-
cess to ensure that every template dsDNA type has access to
a compatible adapter. In this way, adapters are introduced
in a competitive reaction that provides enough compatible
sequences to hybridize with all possible sticky-ended tem-
plate molecules. The overhangs of the XACTLY adapters
create the potential for self-hybridization and ligation; con-
sequently, the adapters are not phosphorylated to prevent
adapter dimer formation.
During the initial step of XACTLY, we treat the template
DNA with polynucleotide kinase to phosphorylate 5′ ter-
mini. Otherwise, we do not alter the template DNA termini.
Next, we perform a two-step ligation. First, we ligate the
5′ phosphorylated template DNA to a pool of unphospho-
rylated, UEI-containing XACTLY adapters. This first liga-
tion occurs between the 3′ end of the forward (P5) adapter
and the 5′ end of the DNA template. Next, we purify to re-
moves excess, unligated adapters. Finally, we phosphorylate
the 5′ ends of the XACTLY adapters and perform a sec-
ond ligation––this time between the 5′ end of the reverse
(P7) adapter and the 3′ end of the DNA template––in or-
der to complete the dsDNA library molecule. Fully formed
XACTLYmolecules are then indexed and amplified using a
universal P5 primer (IS4) and a uniquely indexed P7 primer
(7). Following Illumina paired-end sequencing, the UEI is
used to classify sequence reads by the type, length and se-
quence of the overhang.
Assessing the identification of DNA termini
Accuracy and precision. To determine the accuracy of the
XACTLY assay we constructed a pool of 12 synthetic
double-stranded control oligos, each designed to have a spe-
cific length and type (3′ or 5′) of single-stranded overhang.
Each control oligo contained a unique 50 bp core and a
common structure: blunt terminus on one side, and a 5′ or 3′
overhang of a specific length (1–6 nt) on the other side (Fig-
ure 2A). We generated XACTLY libraries using this pool of
oligos as template. After sequencing the XACTLY libraries,
we used theUEIs on the reverse read (P7) to quantify the as-
say’s accuracy (see Limiting to Reverse Reads) by compar-
ing how often the overhang indicated by the adapter UEI
correctly matched the overhang engineered on the dsDNA
control template. We limited analysis to reverse reads be-
cause the UEI present on the reverse adapter is more ac-
curate in predicting the correct overhang than when we in-
cluded the UEI present on both adapters (Figure 2B). Our
model for explaining this phenomenon is provided in Sup-
plementary Figure S1.
We measured the accuracy and precision of XACTLY
using the control oligo pools, limiting the dataset to cor-
rectly formed library molecules (see Methods). We first cal-
culated how often we captured the correct overhang type
and length. As shown in Figure 2B, the overall UEI accu-
racy over each overhang type and length is 84.94 ± 0.72%
(95% C.I.). Next, we measured the precision of each UEI
by counting the times each UEI adapter was observed lig-
ated to each type of synthetic oligo. For all overhang lengths
and types tested, the most common ligation event is the cor-
rect one, with the exception of the 5′ 1-nt overhang (Figure
2C, asterisks indicate the correct ligation event). Overall, 3′
UEIs have higher fidelity than the 5′. UEI errors, when they
occurred, often included ligation to the same type, but the
wrong length of overhang, most commonly off by one nu-
cleotide. Measurement of recall shows that for every over-
hang type and length considered, the proportion of control
oligo ends ligated to the known correctUEI i.e. the expected
UEI is the highest (Supplementary Figure S2).
Base composition. To determine if ligation accuracy or ef-
ficiency is influenced by the base composition of the over-
hangs, we used the sequence data and UEI data to de-
termine the nucleotide sequence of each recovered single-
stranded overhang. Due to the architecture of XACTLY li-
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Figure 1. Schematic overview of the XACTLY method designed for use on Illumina sequencing platforms. Modified and dephosphorylated Illumina Y-
adapters contain a 7nt-barcode – called a Unique End Identifier (short multi-colored rectangles) – that denotes a discrete terminus type and length. The
length of the overhang is represented by the corresponding number of random bases (shown as Ns), with the exception of a blunt end (no additional
bases). Template DNA is first phosphorylated in preparation for adapter ligation but not end-polished, leaving intact any natively sticky or blunt ends. The
XACTLY adapter set is then hybridized and ligated to the template DNA. A second round of phosphorylation and ligation seals the nicks present due to
the 5′ dephosphorylated adapters. Libraries are then ready for PCR amplification using Illumina-compatible indexing primers (P5 and P7).
braries, the bases present in the 5′ overhangs derive from
the insert template molecule, in this case the control oligo,
whereas 3′ overhangs are derived from the DNA overhang
of the adapter itself. We observe a uniform distribution
of nucleotides for each overhang type and length except
for 5′ 1-nt overhangs, where we observe an excess of cy-
tosine (Figure 2D). To evaluate whether this cytosine bias
is a product of the oligo synthesis process, we prepared
standard end-repaired libraries (NEBNext® Ultra II) of
our synthetic control oligos. The end repair step removes
3′ overhangs but fills-in 5′ overhangs via polymerase ac-
tivity, allowing us to characterize the base composition of
the synthetic DNA 5′ overhangs. Within the standard end-
repaired libraries of the control oligos, we also observe
an elevated read count of 5′ 1-nt cytosines. Therefore, our
observations are likely to derive from biases in the cus-
tom oligo synthesis and not from biases introduced during
ligation.
Detecting known overhangs at low concentrations
To evaluate the ability of XACTLY to detect the pres-
ence of a specific fraction of DNA molecules with a spe-
cific terminus type in a background of extraneous DNA
molecules, we generated a dilution series by mixing DNA
with a single known overhang sequence into a pool of
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Figure 2. Accuracy and precision using synthetic double-stranded control oligos. (A) Design schematic of control oligos – one blunt end, an identifiable
50 base pair UEI core, and an overhang of specific length and type on either end (purple rectangles). (B) Across replicate libraries, accuracy in overhang
determination is highest when only overhanging UEIs are only considered when in reverse reads (includes blunt end UEIs from both reads), (C) Precision
of UEI/control oligo combinations by UEI type. Columns are control oligo overhangs. Rows are UEI adapter overhangs. Asterisks show correct com-
binations; error bars show one standard deviation across libraries. (D) Base composition of overhangs by overhang type and length. Only overhangs for
correct UEI/control oligo combinations are considered; proportions are means across libraries.
DNA fragments with diverse overhangs. We created the
pool of diverse termini by sonication (Diagenode Biorup-
tor) and size selection of NA12878 genomic DNA (gDNA).
We created DNA with a single known overhang by di-
gesting NA12878 gDNA with the restriction endonuclease
MluCI, which creates 5′ 4-nt overhangs of the sequence
AATT.
First, we sequenced XACTLY libraries generated from
the sonicated template and from the MluCI-digested tem-
plate DNA to characterize termini in both samples. The
overhang length profile for the sonicated sample (Figure
3A) shows that sonication shearing of DNA creates a non-
random profile characterized by a prevalence of bluntDSBs
followed by breaks leaving 1- to 4-nt overhangs on both the
5′ and 3′ termini with an excess for 3′ 1-nt and 3′ 2-nt over-
hangs (Figure 3B). We also verify that neither sequencing
depth nor the sequencer used affected observed end profiles
(see downsampling data in Methods, Supplementary Fig-
ure S3 and Supplementary Table S4). Given our previous
observations, 5′1 overhangs are likely underrepresented. As
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Figure 3. Restriction digest experiments. (A) Overhang counts, divided by total per library, across two replicate libraries for 100% mechanically sheared
DNA. (B) Overhang counts, divided by total per library, across two replicate libraries for 100%MluCI digestedDNA.Values aremeans across two libraries;
error bars showmaximum andminimum value. (C)MluCI target sequence abundance with increasing concentration ofMluCI. As the percentage ofMluCI
digested DNA increases (x-axis), so does the frequency of its target sequence (AATT) among 5′ overhang sequences (y-axis). (D) MluCI target sequence is
identifiable even in 1%MluCI digested DNA. Points are counts of individual overhang sequences, divided by the sum of all such counts per library. Mean
counts across two replicate libraries of only mechanically sheared DNA (x-axis) are shown against mean counts across two replicate libraries of 1%MluCI
digested DNA (y-axis). The percent error of each count in 1%MluCI digested DNA was computed, using the count in mechanically sheared DNA as the
expected value. All sequences for which this value, rounded to the thousandths place, fell at or above the 99.9th percentile of the distribution are shown
labeled. The target sequence (AATT) has the highest percent error (6.2%) and is the only sequence with a value at or above the 99.9th percentile of the
distribution (P < 0.001).
expected for MluCI, the length distribution for the MluCI-
digested DNA shows predominately 5′ 4-nt overhangs (Fig-
ure 3B).
We mixed defined amounts of the MluCI-digested DNA
to the sonicated DNA sample and generated XACTLY li-
braries from the pooledmixtures. The pools contained from
1% to 50% MluCI-digested DNA. We calculated the per-
centage of sequence reads in each library that were at-
tributed to 5′ AATT overhangs (Figure 3C, Supplementary
Table S5). Overall, there is concordance between the known
MluCI fraction in the library pool and the proportion of
termini correctly recovered within the sequenced data and
reported as 5′ 4-nucleotide overhangs with the AATT over-
hang. Libraries with higher amounts of MluCI-digested
DNA (100–10%) however show a lower than expected pro-
portion of 5′ AATT overhangs. This is likely due to satura-
tion of the available, compatible overhangs in the XACTLY
pool for the specific overhang type, length, and sequence
of this restriction product. Thus, for samples that are dom-
inated by a specific species of overhang type, length, and
sequence, the percentage detected by XACTLY may be an
underestimate. The underestimate is also likely affected by
MluCI products ligating to other, similar XACTLY over-
hangs. For example, 5′ AATTT is enriched in these MluCI
spike in experiments. This may be due to mis-ligation or
residual exonuclease activity acting on the other strand, cre-
ating longer overhangs.
Next, we estimated the concentration of MluCI-digested
DNA at which we lose the 5′ AATT signal. We com-
pared the sonicated libraries containing titrated amounts
of MluCI-digested DNA to the control sonicated library
that contained no spiked 5′ AATT overhangs. Even at
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Figure 4 . Overhangs created by enzymatic DNA shearing. Overhang counts, base composition of overhangs, and overhang sequences in a gDNA pool
treated with the DNaseI (A–C) and Micrococcal nuclease (D–F). Input DNA for all libraries is human genomic DNA extracted from GM12878 cells.
All results are the average of two independent libraries; error bars on the overhang abundance plots show maximum and minimum value. In c and f, we
computed the difference between the normalized 3′ and 5′ count of each overhang sequence, divided by the mean of the two counts. Shown in text in C
and F are sequences for which this value was significant (above the upper 99th percentile of the distribution).
the lowest dilution in the series (1% MluCI) we are able
to detect an excess of 5′ AATT overhangs over all other
overhangs, P < 0.001 (Figure 3D). This observation sug-
gests that the XACTLY assay can detect and describe
the presence of overhang motifs that make up <1% of a
library.
Overhang profile of common DNA nucleases
Nucleases are broad group of enzymes utilized in nearly
every aspect of molecular biology, including cloning, gene
editing, and fragmentation. General nucleases such as
DNaseI or Micrococcal Nuclease (MNase) are used ex-
tensively in DNA footprinting and chromatin immuno-
precipitation assays to interrogate DNA-protein interac-
tions. To describe the digestion preferences of nucleases,
researchers employ a variety of low throughput and time-
consuming molecular biology, microarray, and sequenced-
based methods (26–33). Because XACTLY libraries can
assay DNA ends in an unbiased high-throughput man-
ner, we used our assay to characterize with high res-
olution genomic DNA termini fragmented via nuclease
digestion.
We generated XACTLY libraries using the two widely
used endonucleases, DNaseI and MNase. The overhang
length profile for DNaseI-digested nakedDNA (Figure 4A)
shows a prevalence of 3′ 2-nt overhangs, as well as 5′ 2-nt to
4-nt overhangs. Of the latter, overhangs of three ormore nu-
cleotides are GC-rich (Supplemental Figure 3A). XACTLY
adapters used in this study extend only to 6-nt, however the
relative abundance of 6-nt overhangs in the overhang length
distribution plot suggests that DNaseI creates overhangs
greater than 6-nt in length. The overhang base composi-
tion profile of DNaseI-digested DNA (Figure 4B) shows
a decreasing preference for cytosine in the 5′ overhang as
the length of the overhang increases, and a slight preference
for 3′1-nt thymine. The base composition of nucleotides up-
stream of DNaseI cut sites (Supplementary Figure S4A)
shows a preference for cutting DNA at A/T sites in the -1
position of 5′ overhangs. Sequences of overhangs created by
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Figure 5. Effect of blood collection tubes on human cfDNA length and overhang profiles of control oligos. Various blood collection tubes containing
whole blood were spiked with synthetic control oligos and incubated for a duration of 0, 4 or 24 h. DNA extracted from each tube contained in a mixture
of human cfDNA and synthetic oligos, and was used as template for XACTLY libraries. To control for the effect of time and extraction protocol on DNA
termini, the same procedure was performed with control oligos spiked into tubes of water and PBS. (A) Tapestation electrophoresis trace showing the size
distribution of XACTLY libraries generated from each tube and timepoint. Control oligo – bands corresponding to control oligos library size ∼200 bp.
cfDNA (mono) – mononucleosome band at ∼300 bp; cfDNA (multi) – multinucleosomal bands > 400 bp, demonstrating a ladder-like pattern of DNA
fragmentation. cfDNA (multi) appear from 0 to 24 ho in RTT, and at 24 h in YTT and PTT; nomulti-nucleosome bands are seen in the Streck tubes; Dimer
– small amount of adapter dimers seen in the library. (B) Percentage of reads matching known control oligo sequences at different time points in different
collection tube types. Control oligos disappear from RTT and YTT more quickly than control tubes, with the greatest reduction in RTT. Control oligo
levels remain stable in Streck tubes, water and PBS, and to a lesser extent in PTT. (C) Differences between expected and observed control oligo overhang
lengths demonstrate loss in overhang length in RTT by 4 h and by 24 h in YTT. Shown are differences from expected length between –1 (i.e. chewed back
by one base) and –5 (the 99th percentile of the distribution); error bars show maximum and minimum values.
DNaseI digestion are primarily 5′ GC-rich overhangs (Fig-
ure 4C).
Conversely, the overhang length plot forMNase-digested
DNA (Figure 4D) shows that MNase has a strong prefer-
ence for the creation of blunt DNA termini (39.5% of the
overhang data), with longer overhangs becoming decreas-
ingly likely. When an overhang is produced, MNase shows
an overall preference for creating A/T rich 5′ overhangs
(Figure 4E, F). The base composition of nucleotides up-
stream (5′) of MNase cut sites corroborates early studies
that observed that MNase is more likely to cut 5′ to A or
T than C or G (29,33). As expected, we see a preference for
cleaving on the 5′ side of A or T whether the termini were
blunt or overhanging. Nucleotides downstream (3′) tend to
also preference A/T but following a pyrimidine on the 3′
side of the cut (Supplementary Figure S4B). (Supplemen-
tary Table S6).
Recovery of DNA termini generated by in vivo nuclease ac-
tivity in whole blood
Recently, circulating cell-free DNA (cfDNA) profiling has
garnered considerable attention for use in non-invasive pre-
natal testing and cancer diagnostics (34–36). Obtaining high
quality DNA from blood plasma begins with blood collec-
tion itself. Blood coagulation or clotting is a process asso-
ciated with increased nuclease activity (37–40) and the type
of blood collection tube (BCT) has been shown to affect
the quantity and quality of a cfDNA extract (41). Here, we
assayed how common BCTs maintain cfDNA integrity by
constructing XACTLY libraries of cfDNA extracted from
various BCTs spiked with known control oligos (described
above). We included BCTs containing commonly used an-
ticoagulants (Supplementary Table S2), and a control tube
without anticoagulants (red top tube; RTT).
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Before extracting plasma (or serum) and isolating cfDNA
(see Materials and Methods), we spiked control oligos into
each of four tube types. Mixtures of control oligos and
cfDNA were extracted at 0, 4 and 24 h following the oligo
spike-in and converted into XACTLY libraries. In Streck®
BCTs (SBCTs), which contain additives that inhibit nu-
clease activity and cell lysis, the human cfDNA fragment
length profile or abundance does not change over time. Con-
versely, multi-nucleosome fragments appears in YTTs (an-
ticoagulant – citrate), and PTTs (anticoagulant – potassium
EDTA) at 24 h, reminiscent of apoptotic cellular gDNA
(42) (Figure 5A). In the RTTs, multi-nucleosome fragments
are seen as early as 0 h suggesting that apoptotic processes
may be initiated during blood coagulation that are associ-
ated with higher nucleolytic activity.
The incubation of whole blood containing control oli-
gos prior to cfDNA extraction allowed us to quantify the
amount of loss or change of known DNA ends due to nu-
clease(s) that remained active following the blood draw. It
also provided us with an opportunity to assess the artefac-
tual effect of sample preparation on native DNA breaks by
evaluating control oligos spiked into water and PBS nega-
tive controls that underwent incubation and extraction. For
each time-point and blood collection tube, including nega-
tive controls, we evaluated the XACTLY UEIs ligated to
the control oligos and compared them with the overhang
profile obtained from control oligos libraries that had not
undergone incubation or extraction. In this way, we can
detect if the original termini type of the control oligo has
been altered by nuclease activity present in each sample. The
overhang profiles of libraries generated from control oligos
spiked into water resemble those of the native control oligo
libraries.
We observe little loss or change to the control DNA end
profiles in the SBCTs, the PTTs, or the negative controls
(Figure 5A–C). In YTTs, which do not contain any known
nuclease inhibitors, we observe changes in both 3′ and 5′
overhang profiles. These changes indicate the presence of
one or more active circulating exonucleases (Figure 5C).
By 24 h, the 3′ overhang signal of control oligos is signif-
icantly diminished in YTTs, suggesting that the 3′ to 5′ ex-
onuclease(s) may be more processive than the 5′ to 3′ ex-
onuclease(s). In the RTTs, we observe the complete loss of
3′ overhang counts within 4 h, as well as depletion of true
blunt-ends, identified by the generation of new overhangs
on formerly blunt-ended molecules. By 24 h, the control
oligos are no longer visible in RTTs (Figure 5A, B), as is
expected in an environment with high nuclease activity. In
sum, these observations show that the XACTLY method
discerns changes in overhang patterns of cfDNA and can
be used to investigate the effect(s) of circulating nucleases
in the blood.
DISCUSSION
Most NGS library preparation methods to date end-repair
DNA in preparation for sequencing, obliterating precise
signals of dsDNA termini degradation and fragmentation.
We have developed a novel NGS assay, XACTLY, to in-
terrogate the termini of fragmented DNA. When applied
to a population of extracted dsDNA fragments, XACTLY
recovers, tags, and prepares overhanging and blunt-ended
molecules for sequencing. Our bioinformatics pipeline then
generates a DNA termini profile, reporting the relative
abundance of all lengths and types (5′ and 3′) of single-
stranded overhangs, if present, on eachDNA fragment with
an overall accuracy between 80 and 90%. The method si-
multaneously obtains the nucleotide sequence of each avail-
able single-stranded overhang. This feature allows for di-
rect observation of overhang sequences that follow cleavage
events as well as the precise genomic location of each frag-
ment end.
Within one day, the XACTLY assay can be performed
with as little as 1 nanogram of fragmented DNA template.
The analyses described here required low depth of coverage,
i.e. fewer than 200 000 read pairs, making XACTLY sig-
nificantly cost effective as a DNA termini exploration tool
when compared to NGS assays that require multi-fold cov-
erage. Together these attributes make XACTLY a more ac-
cessible NGS-based assay.
XACTLY can be applied as a novel NGS research and
discovery tool to characterize in vitro DNA fragmentation
or, in the unique context of cell-free DNA, the products of
in vivo genomic DNA fragmentation. The results presented
here demonstrate that the XACTLY method corroborates
several previous observations about the types of fragmenta-
tion products generated by endonucleases. Using XACTLY
we characterize the overhangs at dsDNA breaks generated
via mechanical or enzymatic cleavage in vitro. We show that
XACTLY can identify restriction products even at our low-
est titration of 1%.
For exploring broad biological signals on DNA frag-
ment ends, the assay leverages the distinct benefits of high-
throughput shotgun sequencing, providing a snapshot of a
diverse population of molecules whose end profiles remain
consistent even at extremely low depths of sequencing cov-
erage. In contrast, NGS-based assays that involve rare vari-
ant detection require orders of magnitude of sequencing
data, amounting to hundreds of millions of shotgun reads
to achieve 30X coverage of human genome. For applica-
tions that want to examine specific allelic variants along with
the DNA overhang characteristics, higher DNA inputs and
sequencing depth or targeted enrichment is always recom-
mended.
Using XACTLY we show that the degradation of
cfDNA ends varies depending on the blood collection
tube/anticoagulant used. While the importance of blood
collection tubes in cfDNA recovery has been described pre-
viously (43–45), XACTLY reveals precisely how best prac-
tice sample collection enables recovery of cfDNA fragments
that remain unaltered from the time of blood draw. This
observation may be of particular interest in clinical and re-
search settings where use of techniques to assay rare tumor-
derived cfDNA fragments has surged in recent years.
Although not presented, the XACTLY NGS assay pro-
tocol can be easily modified for applications with high
molecular weight DNA input such as genomic DNA and
chromatin-bound DNA to examine global in situ double-
stranded DNA breaks and to characterize effects of altered
nuclease activity in response to experimental intervention.
With the growing use of CRISPR-Cas9 and other gene-
editing tools, XACTLY may also prove useful in the char-
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acterization of cleavage products produced specifically by
various Cas9 enzymes or other programmable and/or novel
nucleases.
Enrichment or depletion strategies are also feasible with
minimal modification to the described method. By synthe-
sizing specific overhang adapters, or by modifying the pool
to omit or include overhangs of interest, the method can
be transformed into a targeted tool for isolating known or
suspected DNA termini, whether by type, length and/or se-
quence.
To date no high-throughput assay exists for identify-
ing the termini of extracted fragmented DNA or single-
stranded overhang sequences generated by nuclease activ-
ity or other cleavage events. We hope future research ap-
plications of the XACTLY assay provide an avenue for un-
derstanding the sequence preferences and cleavage prod-
ucts of apoptotic and other human endogenous nucleases,
for example, in liquid biopsy and cell-free DNA research.
In sum, XACTLY is a new high-throughput, hypothesis-
free method for characterizing fragmented DNA termini,
adding new information about molecular history for analy-
sis of cell-free and other fragmented DNA molecules.
DATA AVAILABILITY
Raw sequencing data generated from XACTLY libraries of
sheared gDNA (NA12878) are available in Bioproject PR-
JNA579700.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
The authors would like to thank Dr David Haussler for his
advisory role during the development of the method and
analysis of data, as well as Jessica Morgan Garcia for her
support and assistance performing labwork, and graphic
design for figure generation.
Author contributions: R.E.G., K.H., B.S. conceived the in-
vestigation; R.E.G., D.H., K.H., C.T., V.R. designed exper-
iments and interpreted results; N.K.S. and V.R. performed
data analyses and visualization; C.N., C.T., V.R., K.H., J.K.
performed laboratory work; K.H., N.K.S., C.T., V.R. wrote
the manuscript with contributions from all co-authors.
FUNDING
Gordon and BettyMoore Foundation [GBMF 3804 to B.S.
and R.E.G.]; NIH SBIR Award [R43CA232935]. Funding
for open access charge: Claret Bioscience LLC.
Conflict of interest statement.R.E.G., B.S., K.H., D.H.,
C.T., V.R., C.N., N.K.S. are cofounders, shareholders, advi-
sors and/or officers/consultants of Claret Bioscience LLC,
a genomics company that commercializes sequencing and
analysis tools for cfDNA and other nucleic acid sources.
The described methods are the subject of active patent ap-
plications.
REFERENCES
1. Didenko,V.V. and Hornsby,P.J. (1996) Presence of double-strand
breaks with single-base 3′ overhangs in cells undergoing apoptosis
but not necrosis. J. Cell Biol., 135, 1369–1376.
2. Didenko,V.V., Ngo,H. and Baskin,D.S. (2003) Early necrotic DNA
degradation: presence of blunt-ended DNA breaks, 3′ and 5′
overhangs in apoptosis, but only 5′ overhangs in early necrosis. Am. J.
Pathol., 162, 1571–1578.
3. Widlak,P., Li,P., Wang,X. and Garrard,W.T. (2000) Cleavage
preferences of the apoptotic endonuclease DFF40 (caspase-activated
DNase or nuclease) on naked DNA and chromatin substrates. J. Biol.
Chem., 275, 8226–8232.
4. Enari,M., Sakahira,H., Yokoyama,H., Okawa,K., Iwamatsu,A. and
Nagata,S. (1998) A caspase-activated DNase that degrades DNA
during apoptosis, and its inhibitor ICAD. Nature, 391, 43–50.
5. Nagata,S., Nagase,H., Kawane,K., Mukae,N. and Fukuyama,H.
(2003) Degradation of chromosomal DNA during apoptosis. Cell
Death Differ., 10, 108–116.
6. Goodwin,S., McPherson,J.D. and McCombie,W.R. (2016) Coming of
age: ten years of next-generation sequencing technologies. Nat. Rev.
Genet., 17, 333–351.
7. Meyer,M. and Kircher,M. (2010) Illumina sequencing library
preparation for highly multiplexed target capture and sequencing.
Cold Spring Harb. Protoc., 2010, doi:10.1101/pdb.prot5448.
8. Adey,A., Morrison,H.G., Asan, Xun,X., Kitzman,J.O., Turner,E.H.,
Stackhouse,B., MacKenzie,A.P., Caruccio,N.C., Zhang,X. et al.
(2010) Rapid, low-input, low-bias construction of shotgun fragment
libraries by high-density in vitro transposition. Genome Biol., 11,
R119.
9. Collins,A.R. (2004) The comet assay for DNA damage and repair:
principles, applications, and limitations.Mol. Biotechnol., 26,
249–261.
10. Singh,N.P., McCoy,M.T., Tice,R.R. and Schneider,E.L. (1988) A
simple technique for quantitation of low levels of DNA damage in
individual cells. Exp. Cell Res., 175, 184–191.
11. Ansari,B., Coates,P.J., Greenstein,B.D. and Hall,P.A. (1993) In situ
end-labelling detects DNA strand breaks in apoptosis and other
physiological and pathological states. J. Pathol., 170, 1–8.
12. Ostling,O. and Johanson,K.J. (1984) Microelectrophoretic study of
radiation-induced DNA damages in individual mammalian cells.
Biochem. Biophys. Res. Commun., 123, 291–298.
13. Tice,R.R., Agurell,E., Anderson,D., Burlinson,B., Hartmann,A.,
Kobayashi,H., Miyamae,Y., Rojas,E., Ryu,J.C. and Sasaki,Y.F. (2000)
Single cell gel/comet assay: guidelines for in vitro and in vivo genetic
toxicology testing. Environ. Mol. Mutagen., 35, 206–221.
14. Gavrieli,Y., Sherman,Y. and Ben-Sasson,S.A. (1992) Identification of
programmed cell death in situ via specific labeling of nuclear DNA
fragmentation. J. Cell Biol., 119, 493–501.
15. Crosetto,N., Mitra,A., Silva,M.J., Bienko,M., Dojer,N., Wang,Q.,
Karaca,E., Chiarle,R., Skrzypczak,M., Ginalski,K. et al. (2013)
Nucleotide-resolution DNA double-strand break mapping by
next-generation sequencing. Nat. Methods, 10, 361–365.
16. Canela,A., Sridharan,S., Sciascia,N., Tubbs,A., Meltzer,P.,
Sleckman,B.P. and Nussenzweig,A. (2016) DNA breaks and end
resection measured genome-wide by end sequencing.Mol. Cell, 63,
898–911.
17. Chan,K.C., Jiang,P., Sun,K., Cheng,Y.K., Tong,Y.K., Cheng,S.H.,
Wong,A.I., Hudecova,I., Leung,T.Y., Chiu,R.W. et al. (2016) Second
generation noninvasive fetal genome analysis reveals de novo
mutations, single-base parental inheritance, and preferred DNA ends.
PNAS, 113, E8159–E8168.
18. Frock,R.L., Hu,J., Meyers,R.M., Ho,Y.J., Kii,E. and Alt,F.W. (2015)
Genome-wide detection of DNA double-stranded breaks induced by
engineered nucleases. Nat. Biotechnol., 33, 179–186.
19. Yan,W.X., Mirzazadeh,R., Garnerone,S., Scott,D., Schneider,M.W.,
Kallas,T., Custodio,J., Wernersson,E., Li,Y., Gao,L. et al. (2017)
BLISS is a versatile and quantitative method for genome-wide
profiling of DNA double-strand breaks. Nat. Commun., 8, 15058.
20. Kircher,M. (2012) Analysis of high-throughput ancient DNA
sequencing data.Methods Mol. Biol., 840, 197–228.
21. Li,H. (2013) Aligning sequence reads, clone sequences and assembly
contigs with BWA-MEM. arXiv doi: https://arxiv.org/abs/1303.3997,
16 March 2013, preprint: not peer reviewed.
PAGE 13 OF 13 Nucleic Acids Research, 2020, Vol. 48, No. 8 e47
22. Li,H., Handsaker,B., Wysoker,A., Fennell,T., Ruan,J., Homer,N.,
Marth,G., Abecasis,G., Durbin,R. and Genome Project Data
Processing, S. (2009) The Sequence Alignment/Map format and
SAMtools. Bioinformatics, 25, 2078–2079.
23. Sˇosˇic´,M. and Sˇikic´,M. (2017) Edlib: a C/C ++ library for fast, exact
sequence alignment using edit distance. Bioinformatics, 33,
1394–1395.
24. Kent,W.J., Sugnet,C.W., Furey,T.S., Roskin,K.M., Pringle,T.H.,
Zahler,A.M. and Haussler,D. (2002) The human genome browser at
UCSC. Genome Res., 12, 996–1006.
25. Li,H. and Durbin,R. (2009) Fast and accurate short read alignment
with Burrows-Wheeler transform. Bioinformatics, 25, 1754–1760.
26. Crawford,G.E., Davis,S., Scacheri,P.C., Renaud,G., Halawi,M.J.,
Erdos,M.R., Green,R., Meltzer,P.S., Wolfsberg,T.G. and Collins,F.S.
(2006) DNase-chip: a high-resolution method to identify DNase I
hypersensitive sites using tiled microarrays. Nat. Methods, 3, 503–509.
27. Sabo,P.J., Kuehn,M.S., Thurman,R., Johnson,B.E., Johnson,E.M.,
Cao,H., Yu,M., Rosenzweig,E., Goldy,J., Haydock,A. et al. (2006)
Genome-scale mapping of DNase I sensitivity in vivo using tiling
DNA microarrays. Nat. Methods, 3, 511–518.
28. Koohy,H., Down,T.A. and Hubbard,T.J. (2013) Chromatin
accessibility data sets show bias due to sequence specificity of the
DNase I enzyme. PLoS One, 8, e69853.
29. Dingwall,C., Lomonossoff,G.P. and Laskey,R.A. (1981) High
sequence specificity of micrococcal nuclease. Nucleic Acids Res., 9,
2659–2673.
30. Rushizky,G.W., Knight,C.A., Roberts,W.K. and Dekker,C.A. (1960)
A map of the products resulting from the action of micrococcal
nuclease on thymus deoxyribonucleic acid and its use as a guide to
specificity. Biochem. Biophys. Res. Commun., 2, 153–158.
31. Dekker,C.A. (1960) Nucleic acids selected topics related to their
enzymology and chemistry. Annu. Rev. Biochem., 29, 453–474.
32. Sulkowski,E. and Laskowski,M. Sr (1962) Mechanism of action of
micrococcal nuclease on deoxyribonucleic acid. J. Biol. Chem., 237,
2620–2625.
33. Drew,H.R. (1984) Structural specificities of five commonly used
DNA nucleases. J. Mol. Biol., 176, 535–557.
34. Aravanis,A.M., Lee,M. and Klausner,R.D. (2017) Next-Generation
sequencing of circulating tumor DNA for early cancer detection. Cell,
168, 571–574.
35. Diehl,F., Schmidt,K., Choti,M.A., Romans,K., Goodman,S., Li,M.,
Thornton,K., Agrawal,N., Sokoll,L., Szabo,S.A. et al. (2008)
Circulating mutant DNA to assess tumor dynamics. Nat. Med., 14,
985–990.
36. Fan,H.C., Blumenfeld,Y.J., Chitkara,U., Hudgins,L. and Quake,S.R.
(2008) Noninvasive diagnosis of fetal aneuploidy by shotgun
sequencing DNA from maternal blood. PNAS, 105, 16266–16271.
37. Chitrabamrung,S., Rubin,R.L. and Tan,E.M. (1981) Serum
deoxyribonuclease I and clinical activity in systemic lupus
erythematosus. Rheumatol. Int., 1, 55–60.
38. Ershova,E., Sergeeva,V., Klimenko,M., Avetisova,K., Klimenko,P.,
Kostyuk,E., Veiko,N., Veiko,R., Izevskaya,V., Kutsev,S. et al. (2017)
Circulating cell-free DNA concentration and DNase I activity of
peripheral blood plasma change in case of pregnancy with
intrauterine growth restriction compared to normal pregnancy.
Biomed Rep, 7, 319–324.
39. Tamkovich,S.N., Cherepanova,A.V., Kolesnikova,E.V., Rykova,E.Y.,
Pyshnyi,D.V., Vlassov,V.V. and Laktionov,P.P. (2006) Circulating
DNA and DNase activity in human blood. Ann. N. Y. Acad. Sci.,
1075, 191–196.
40. Patel,P.S., Patel,B.P., Rawal,R.M., Raval,G.N., Patel,M.M., Patel,J.B.,
Jha,F.P. and Patel,D.D. (2000) Evaluation of serum alkaline DNase
activity in treatment monitoring of head and neck cancer patients.
Tumour Biol., 21, 82–89.
41. Barra,G.B., Santa Rita,T.H., de Almeida Vasques,J., Chianca,C.F.,
Nery,L.F. and Santana Soares Costa,S. (2015) EDTA-mediated
inhibition of DNases protects circulating cell-free DNA from ex vivo
degradation in blood samples. Clin. Biochem., 48, 976–981.
42. Wylie,A.H. (1980) Glucocorticoid-induced thymocyte apoptosis is
associated with endogenous endonuclease activation. Nature, 284,
555–556.
43. Kang,Q., Henry,N.L., Paoletti,C., Jiang,H., Vats,P.,
Chinnaiyan,A.M., Hayes,D.F., Merajver,S.D., Rae,J.M. and
Tewari,M. (2016) Comparative analysis of circulating tumor DNA
stability In K3EDTA, Streck, and CellSave blood collection tubes.
Clin. Biochem., 49, 1354–1360.
44. Wong,D., Moturi,S., Angkachatchai,V., Mueller,R., DeSantis,G., van
den Boom,D. and Ehrich,M. (2013) Optimizing blood collection,
transport and storage conditions for cell free DNA increases access to
prenatal testing. Clin. Biochem., 46, 1099–1104.
45. Lahiri,D.K. and Schnabel,B. (1993) DNA isolation by a rapid
method from human blood samples: effects of MgCl2, EDTA,
storage time, and temperature on DNA yield and quality. Biochem.
Genet., 31, 321–328.
